Suppr超能文献

通过代谢工程改造 L-丝氨酸生物合成途径可提高酿酒酵母中的谷胱甘肽产量。

Metabolic engineering of the L-serine biosynthetic pathway improves glutathione production in Saccharomyces cerevisiae.

机构信息

Graduate School of Science, Technology and Innovation, Kobe University, 1-1 Rokkodaicho, Nada-ku, Kobe, Hyogo, 657-8501, Japan.

Graduate School of Nutritional and Environmental Sciences, University of Shizuoka, 52‑1 Yada, Suruga‑ku, Shizuoka, 422‑8526, Japan.

出版信息

Microb Cell Fact. 2022 Aug 6;21(1):153. doi: 10.1186/s12934-022-01880-8.

Abstract

BACKGROUND

Glutathione is a valuable tri-peptide that is industrially produced by fermentation using the yeast Saccharomyces cerevisiae, and is widely used in the pharmaceutical, food, and cosmetic industries. It has been reported that addition of L-serine (L-Ser) is effective at increasing the intracellular glutathione content because L-Ser is the common precursor of L-cysteine (L-Cys) and glycine (Gly) which are substrates for glutathione biosynthesis. Therefore, we tried to enhance the L-Ser biosynthetic pathway in S. cerevisiae for improved glutathione production.

RESULTS

The volumetric glutathione production of recombinant strains individually overexpressing SER2, SER1, SER3, and SER33 involved in L-Ser biosynthesis at 48 h cultivation was increased 1.3, 1.4, 1.9, and 1.9-fold, respectively, compared with that of the host GCI strain, which overexpresses genes involved in glutathione biosynthesis. We further examined simultaneous overexpression of SHM2 and/or CYS4 genes involved in Gly and L-Cys biosynthesis, respectively, using recombinant GCI strain overexpressing SER3 and SER33 as hosts. As a result, GCI overexpressing SER3, SHM2, and CYS4 showed the highest volumetric glutathione production (64.0 ± 4.9 mg/L) at 48 h cultivation, and this value is about 2.5-fold higher than that of the control strain.

CONCLUSIONS

This study first revealed that engineering of L-Ser and Gly biosynthetic pathway are useful strategies for fermentative glutathione production by S. cerevisiase.

摘要

背景

谷胱甘肽是一种有价值的三肽,可通过使用酵母酿酒酵母(Saccharomyces cerevisiae)进行发酵工业生产,广泛应用于制药、食品和化妆品行业。据报道,添加 L-丝氨酸(L-Ser)可有效增加细胞内谷胱甘肽含量,因为 L-Ser 是 L-半胱氨酸(L-Cys)和甘氨酸(Gly)的共同前体,是谷胱甘肽生物合成的底物。因此,我们试图增强酿酒酵母中的 L-Ser 生物合成途径,以提高谷胱甘肽的产量。

结果

与宿主 GCI 菌株(其过量表达参与谷胱甘肽生物合成的基因)相比,单独过表达参与 L-Ser 生物合成的 SER2、SER1、SER3 和 SER33 的重组菌株在 48 h 培养时的谷胱甘肽体积产量分别提高了 1.3、1.4、1.9 和 1.9 倍。我们进一步研究了使用重组 GCI 菌株(其过表达 SER3 和 SER33)作为宿主同时过表达分别参与 Gly 和 L-Cys 生物合成的 SHM2 和 CYS4 基因。结果,过表达 SER3、SHM2 和 CYS4 的 GCI 显示出最高的谷胱甘肽体积产量(64.0±4.9mg/L),在 48 h 培养时,这一值比对照菌株高约 2.5 倍。

结论

本研究首次表明,工程化 L-Ser 和 Gly 生物合成途径是通过酿酒酵母发酵生产谷胱甘肽的有用策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验